Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nanomedicine (London, England)|November 24, 2016
Targeted brain delivery nanoparticles for malignant gliomasMauricio P Pinto, Maximiliano Arce, Basit Yameen, et al.
STAR Protocols|December 6, 2025
Protocol for generation of endothelial cells from human-derived iPSCs and integration into mouse brain explantsIza Erzar, Nora Noll, Roberta Lugano, et al.
International Journal of Molecular Sciences|October 27, 2022
Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous MalformationsMaria Ascencion Globisch, Favour Chinyere Onyeogaziri, Ross Osborne Smith, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 29, 2017
The salivary peptide histatin-1 promotes endothelial cell adhesion, migration, and angiogenesisPedro Torres, Jorge Díaz, Maximiliano Arce, et al.
Nature Cardiovascular Research|December 5, 2024
Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformationFavour C Onyeogaziri, Ross Smith, Maximiliano Arce, et al.
World Neurosurgery|October 14, 2022
Slow-Closing Clip for the Treatment of Nonsaccular Vertebrobasilar Aneurysms: A Retrospective Case SeriesBehnam Rezai Jahromi, Reza Dashti, Oriela Rustemi, et al.
Cell Reports|April 16, 2025
KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformationMaximiliano Arce, Iza Erzar, Fan Yang, et al.
Blood|August 18, 2022
Immunothrombosis and vascular heterogeneity in cerebral cavernous malformationMaria A Globisch, Favour C Onyeogaziri, Suvi Jauhiainen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 11, 2024
Coronary Artery Disease Risk Variant Dampens the Expression of CALCRL by Reducing HSF Binding to Shear Stress Responsive Enhancer in Endothelial Cells In VitroIlakya Selvarajan, Miika Kiema, Ru-Ting Huang, et al.
Stroke|February 23, 2021
Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations: A Preclinical StudyJoppe Oldenburg, Matteo Malinverno, Maria Ascencion Globisch, et al.
Pageof 2